ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

Ann Med Res. 2011; 18(3): 164-167


Our Results of Follow-up and Treatment in Ocular Toxoplasmosis

 

Rumeysa Tanyıldızı*, Tamer Demir*

.



Abstract
Download PDF Post


 

Purpose: To evaluate the importance of clinical findings and treatment modalities in ocular toxoplasmosis.

Materials and Methods: We retrospectively evaluated 20 patients who were diagnosed oculer toxoplasmosis between 2003-2009 in Fırat univercity eye clinic. The diagnosis was determined according to the fundus examination and serological findings.

Results: Twelve (%60) female and 8 (%40) male of 20 patients were involved and the mean of the patients age was 25 (13-48) years. The mean follow up time was 30 (8-62) months. Twelve (%60) patients had active retinochoroiditis and 8 (%40) patients had retinochoroidal skar. Twelve (%60) patients who had active retinochoroiditis were treated with antiparasitic drugs for 4-6 weeks. Four (%33) of the patients in this grup had foveal lesions and 8 (%66) had foveal lesions as well as peripheral retinal involvement. Ocular findings were observed anterior chamber reaction and keratic precipitates in 12 (%60) patients, posterior synechia in 4 (%20) patients and posterior subcapsuler cataract in 2 (%10) patients. Topical steroid and sikloplejik terapy were aplicated to the twelve (%60) patients who had anterior chamber reaction. Recurrence was observed in 4 (%20) patients. The mean improvement of the visual acuity was 1.8 lines in snellen chart. The anterior chamber reaction and size of the lesion were decreased after the treatment.

Conclusion: The diagnosis of oculer toxoplasmosis was determined with clinical and serological findings. Ocular toxoplasmosis can be taken under control by the correct diagnosis and effective treatment. Visual prognosis might be better after the treatment.

Key Words: Ocular Toxoplasmosis; Treatment; Prognosis.





Bibliomed Article Statistics

14
21
31
36
30
49
37
18
21
28
33
22
R
E
A
D
S

13

17

21

13

13

11

16

16

11

10

11

13
D
O
W
N
L
O
A
D
S
010203040506070809101112
2025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.